NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
RECITE
Phase 3 Completed
165 enrolled 22 charts
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
61 enrolled 29 charts
CLAUDIO-01
Phase 1/2 Terminated
31 enrolled 34 charts
MK-2140-002
Phase 2 Terminated
102 enrolled 36 charts
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Phase 1/2 Terminated
8 enrolled 12 charts
Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma
Phase 1/2 Terminated
1 enrolled 3 charts
PAVO
Phase 2 Terminated
22 enrolled 17 charts
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Phase 1/2 Terminated
137 enrolled 31 charts
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
332 enrolled 44 charts
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Phase 2 Terminated
23 enrolled 15 charts
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Phase 1 Completed
56 enrolled 19 charts
PROACC-1
Phase 2 Completed
187 enrolled 24 charts
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
MAESTRO
Phase 3 Completed
693 enrolled 8 charts
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
Phase 1 Terminated
19 enrolled 6 charts
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
Phase 1/2 Terminated
81 enrolled 13 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients
Phase 2 Completed
45 enrolled 14 charts
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
8479217
Phase 1 Completed
6 enrolled 17 charts
V941-001
Phase 1 Terminated
70 enrolled 18 charts
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
6 enrolled 15 charts
Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
Phase 2 Terminated
10 enrolled 10 charts
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Phase 2/3 Terminated
130 enrolled 13 charts
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
Phase 1/2 Completed
138 enrolled 19 charts
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Phase 2 Terminated
315 enrolled 73 charts
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Phase 1/2 Terminated
13 enrolled 24 charts
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Phase 1 Completed
73 enrolled 18 charts
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
28 enrolled 16 charts
QUILT-3.080: NANT Pancreatic Cancer Vaccine
Phase 1/2 Terminated
3 enrolled 13 charts
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Phase 1/2 Terminated
89 enrolled 20 charts
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
Phase 1/2 Terminated
3 enrolled 6 charts
GAMMA
Phase 3 Completed
800 enrolled 11 charts
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Phase 1 Terminated
49 enrolled 33 charts
Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Phase 2 Completed
54 enrolled 17 charts
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
Phase 1 Terminated
78 enrolled 39 charts
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
3 enrolled 9 charts
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
Phase 2 Completed
15 enrolled 9 charts
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
4 enrolled 9 charts
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Phase 2 Completed
730 enrolled 25 charts
MYCure
Phase 1/2 Terminated
22 enrolled 9 charts
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
Phase 1 Completed
52 enrolled 21 charts
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Phase 1 Completed
18 enrolled 14 charts
Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer
Phase 1/2 Completed
42 enrolled 13 charts
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Phase 1 Completed
11 enrolled 13 charts
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Phase 1/2 Completed
46 enrolled 28 charts
CanStem111P
Phase 3 Completed
1,134 enrolled 18 charts